Study of E7389 Liposomal Formulation in Participants With Solid Tumor
Clinical trial NCT03207672 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03207672
- Sponsor
- Eisai Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-18
- Primary completion
- 2018-07-19
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.